NeuroPace, Inc.

Healthcare · Medical Devices · United States

Last price 13.01 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 446.56M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programmin...